Skip to main content
ERAS
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
4
Price
$10.01
Mkt Cap
$5.952B
52W Low
$1.06
52W High
$24.28
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, ERAS was trading at $10.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6B. The 52-week trading range was $1.06 to $24.28. This filing was assessed with an importance score of 4 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ERAS - Latest Insights

ERAS
Apr 28, 2026, 3:58 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
ERAS
Apr 27, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
9
ERAS
Apr 27, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
8
ERAS
Apr 21, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
7
ERAS
Mar 12, 2026, 4:11 PM EDT
Filing Type: 10-K
Importance Score:
8
ERAS
Mar 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
ERAS
Mar 12, 2026, 4:01 PM EDT
Source: Reuters
Importance Score:
7
ERAS
Mar 10, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
ERAS
Mar 05, 2026, 7:01 AM EST
Source: GlobeNewswire
Importance Score:
8
ERAS
Jan 29, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
8